1-6 of 6
Arnon Haran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNMT3A, TET2, and ASXL1 (DTA) Mutations Are Associated with Thrombosis and Bleeding in Patients with Myeloproliferative Neoplasms

Arnon Haran, Avital Wasserstrom, Shlomzion Aumann, Vladimir Vainstein, Romi Kazoom, Batia Roth Jelinek, Ariela Arad, Noa Buchman, Ela Shai, Yossi Kalish, Moshe E Gatt, Eran Zimran
Journal: Blood
Blood (2024) 144 (Supplement 1): 3189.
https://doi.org/10.1182/blood-2024-209783
Published: 2024
Journal Articles

UBE2E3 Supports Survival of Leukemia Stem Cells By Regulation of Polycomb Repression Complex (PRC) 1.1

Vika Miller, Ayat Hija, Mohamed Abdal-Rhaman, Noa Gross Even-Zohar, Michal Saltsman, Aaron Botham, Arnon Haran, Shlomzion Aumann, Vladimir Vainstein, Moshe E Gatt, Brian Raught, Aaron D Schimmer, Boaz Nachmias
Journal: Blood
Blood (2024) 144 (Supplement 1): 5714.
https://doi.org/10.1182/blood-2024-193438
Published: 2024
Journal Articles

Brentuximab Vedotin-Based Regimens for Older Patients with Newly Diagnosed Classical Hodgkin Lymphoma - International, Multi-Center Real-World Experience

Efrat Luttwak, Swetha Kambhampati, Esther Drill, Nivetha Ganesan, Liron Hofstetter, Ronit Gurion, Shlomzion Aumann, Arnon Haran, Mika Geva, Marc Panossian, Robert Stuver, Paul A. Hamlin, Ariela Noy, Alex F. Herrera, Alison Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1668.
https://doi.org/10.1182/blood-2024-212085
Published: 2024
Journal Articles

For Patients with Adverse-Risk Acute Myeloid Leukemia, Frontline FLAG Ida with Venetoclax Is Safe and Efficacious

Baher Krayem, Avraham Frisch, Tsila Zuckerman, Israel Henig, Dana Yehudai-Ofir, Boaz Nachmias, Hazim Khatib, Arnon Haran, Shlomzion Aumann
Journal: Blood
Blood (2024) 144 (Supplement 1): 4269.
https://doi.org/10.1182/blood-2024-204627
Published: 2024
Journal Articles

Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma

Arnon Haran, Noa Gros Even-Zohar, Eyal Lebel, Shlomzion Aumann, Adir Shaulov, Moshe E Gatt, Boaz Nachmias
Journal: Blood
Blood (2023) 142 (Supplement 1): 6277.
https://doi.org/10.1182/blood-2023-187241
Published: 2023
Journal Articles

Outcome of Risk- and Response-Adapted Post-Remission Therapy in Patients with NPM1 AML Treated Intensively

Avraham Frisch, Chezi Ganzel, Yishai Ofran, Baher Krayem, Vladimir Vainstein, Arnon Haran, Boaz Nachmias
Journal: Blood
Blood (2023) 142 (Supplement 1): 4212.
https://doi.org/10.1182/blood-2023-179194
Published: 2023